TY  - GEN
AU  - Virseda-Berdices, Ana
AU  - Requena, Belen
AU  - Berenguer, Juan
AU  - Gónzalez-García, Juan
AU  - Gonzalez-Riano, Carolina
AU  - Díez, Cristina
AU  - Hontañón, Victor
AU  - Muñoz-García, Paula
AU  - Fernandez-Rodriguez, Amanda
AU  - Barbas, Coral
AU  - Resino, Salvador
AU  - Martín-Escolano, Rubén
AU  - Jimenez-Sousa, Maria Angeles
AU  - the Marathon Study Group
PY  - 2025
DO  - 10.1016/j.jiph.2025.102981
UR  - https://hdl.handle.net/20.500.12105/27348
AB  - Background: Despite successful hepatitis C virus (HCV) clearance, some individuals continue to experience liver disease progression. Metabolic dysfunction-associated steatotic liver disease (MASLD) may play a key role in this ongoing progression. This...
LA  - eng
PB  - Elsevier
KW  - HCV eradication
KW  - Lipidomics
KW  - MASLD
KW  - PWH
KW  - Adult
KW  - Antiviral Agents
KW  - Coinfection
KW  - Cross-Sectional Studies
KW  - Disease Progression
KW  - Fatty Liver
KW  - Female
KW  - HIV Infections
KW  - Hepatitis C
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Lipidomics
KW  - Lipids
KW  - Liver Cirrhosis
KW  - Male
KW  - Middle Aged
KW  - Sustained Virologic Response
TI  - Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosis.
TY  - research article
ER  -